Cargando…
Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling
Background: Yanghe Huayan Decoction (YHD), a traditional Chinese medicine, is one of the most common complementary medicine currently used in the treatment of breast cancer (BC). It has been recently linked to suppress precancerous lesion and tumor development. The current study sought to explore th...
Autores principales: | Liu, Xiao-Fei, Li, Jing-Wei, Chen, Hong-Zhi, Sun, Zi-Yuan, Shi, Guang-Xi, Zhu, Jian-Min, Song, Ai-Li, Wang, Ying, Li, Xiang-Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379224/ https://www.ncbi.nlm.nih.gov/pubmed/30429238 http://dx.doi.org/10.1042/BSR20181260 |
Ejemplares similares
-
Correction: Yanghe Huayan Decoction inhibit the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling
Publicado: (2023) -
Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
por: Li, Jingwei, et al.
Publicado: (2019) -
Deciphering the Metabolomics-Based Intervention of Yanghe Decoction on Hashimoto's Thyroiditis
por: Zhang, Xing, et al.
Publicado: (2022) -
Yanghe Decoction Effectively Alleviates Lung Injury and Immune Disorder in Asthmatic Mice Induced by Ovalbumin
por: Li, Cui, et al.
Publicado: (2022) -
Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial
por: Wang, Yiquan, et al.
Publicado: (2018)